JNGLX
Price
$66.43
Change
-$0.41 (-0.61%)
Updated
Jul 17 closing price
Net Assets
4.4B
LHCFX
Price
$18.43
Change
-$0.13 (-0.70%)
Updated
Jul 17 closing price
Net Assets
7.28M
Interact to see
Advertisement

JNGLX vs LHCFX

Header iconJNGLX vs LHCFX Comparison
Open Charts JNGLX vs LHCFXBanner chart's image
Janus Henderson Global Life Sciences D
Price$66.43
Change-$0.41 (-0.61%)
VolumeN/A
Net Assets4.4B
Lord Abbett Health Care F
Price$18.43
Change-$0.13 (-0.70%)
VolumeN/A
Net Assets7.28M
JNGLX vs LHCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCFX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Hold and LHCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. LHCFX (7.28M). LHCFX pays higher dividends than JNGLX: LHCFX (0.47) vs JNGLX (0.36). JNGLX was incepted earlier than LHCFX: JNGLX (27 years) vs LHCFX (6 years). LHCFX (3.19) is less costly to investors than JNGLX (0.80). LHCFX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCFX has a lower initial minimum investment than JNGLX: LHCFX (0) vs JNGLX (2500). LHCFX annual gain was more profitable for investors over the last year : -8.22 vs. JNGLX (-15.74). JNGLX return over 5 years is better than : 2.42 vs. LHCFX (1.36).
JNGLXLHCFXJNGLX / LHCFX
Total Expense Ratio0.800.78103%
Annual Report Gross Expense Ratio0.803.1925%
Fund Existence27 years6 years-
Gain YTD-1.547-4.33036%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B7.28M60,442%
Annual Yield % from dividends0.360.4776%
Returns for 1 year-15.74-8.22191%
Returns for 3 years10.8411.6893%
Returns for 5 years2.421.36178%
Returns for 10 years5.58N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVCX16.08N/A
N/A
MFS New Discovery Value C
BRSJX14.40N/A
N/A
MFS Blended Research Small Cap Eq I
BFIUX18.65N/A
N/A
Baron FinTech R6
JSCZX16.31N/A
N/A
JPMorgan US Small Company R2
TROIX14.62N/A
N/A
T. Rowe Price Overseas Stock I